Current methods force scientists to study life’s fundamental building block when it is dying. PHI’s non-destructive technology brings cells to life by permitting long-term cellular behavior to be observed and quantified without toxic stains.
Since 2011 PHI has provided pioneering scientists with cell analyzers and data analysis software that cost-efficiently reflects the importance of cell health and biological relevance.
PHI was founded by its current management with the support of Lund University and Sweden’s Innovation Agency, VINNOVA. Since early 2014 the PHI stock is publicly traded on AktieTorget.